221 related articles for article (PubMed ID: 22874667)
21. Role of Cdk5 in Amyloid-beta Pathology of Alzheimer's Disease.
Lu TT; Wan C; Yang W; Cai Z
Curr Alzheimer Res; 2019; 16(13):1206-1215. PubMed ID: 31820699
[TBL] [Abstract][Full Text] [Related]
22. Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease.
Chang KH; de Pablo Y; Lee HP; Lee HG; Smith MA; Shah K
J Neurochem; 2010 Jun; 113(5):1221-9. PubMed ID: 20345761
[TBL] [Abstract][Full Text] [Related]
23. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
Shukla V; Skuntz S; Pant HC
Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
[TBL] [Abstract][Full Text] [Related]
24. Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death.
Chang KH; Multani PS; Sun KH; Vincent F; de Pablo Y; Ghosh S; Gupta R; Lee HP; Lee HG; Smith MA; Shah K
Mol Biol Cell; 2011 May; 22(9):1452-62. PubMed ID: 21389115
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-132/212 impairs S-nitrosylation balance and induces tau phosphorylation in Alzheimer's disease.
Wang Y; Veremeyko T; Wong AH; El Fatimy R; Wei Z; Cai W; Krichevsky AM
Neurobiol Aging; 2017 Mar; 51():156-166. PubMed ID: 28089352
[TBL] [Abstract][Full Text] [Related]
26. Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease.
Sadleir KR; Vassar R
J Biol Chem; 2012 Mar; 287(10):7224-35. PubMed ID: 22223639
[TBL] [Abstract][Full Text] [Related]
27. Unveiling Potential Neurotoxic Mechansisms: Pb-Induced Activation of CDK5-p25 Signaling Axis in Alzheimer's Disease Development, Emphasizing CDK5 Inhibition and Formation of Toxic p25 Species.
Lokesh M; Bandaru LJM; Rajanna A; Rao JS; Challa S
Mol Neurobiol; 2024 May; 61(5):3090-3103. PubMed ID: 37968421
[TBL] [Abstract][Full Text] [Related]
28. CDK4 and CDK5 Inhibition Have Comparable Mild Hypothermia Effects in Preventing Drp1-Dependent Mitochondrial Fission and Neuron Death Induced by MPP
Yang SH; Huang CY; Hsieh CY; Chuang JI
Mol Neurobiol; 2020 Oct; 57(10):4090-4105. PubMed ID: 32666227
[TBL] [Abstract][Full Text] [Related]
29. S-Nitrosylation in Alzheimer's disease.
Zhao QF; Yu JT; Tan L
Mol Neurobiol; 2015 Feb; 51(1):268-80. PubMed ID: 24664522
[TBL] [Abstract][Full Text] [Related]
30. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
Nakamura T; Lipton SA
Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
[TBL] [Abstract][Full Text] [Related]
31. Neuronal Nitric Oxide Synthase in Nucleus Accumbens Specifically Mediates Susceptibility to Social Defeat Stress through Cyclin-Dependent Kinase 5.
Yin CY; Huang SY; Gao L; Lin YH; Chang L; Wu HY; Zhu DY; Luo CX
J Neurosci; 2021 Mar; 41(11):2523-2539. PubMed ID: 33500273
[TBL] [Abstract][Full Text] [Related]
32. S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development.
Zhang P; Yu PC; Tsang AH; Chen Y; Fu AK; Fu WY; Chung KK; Ip NY
J Neurosci; 2010 Oct; 30(43):14366-70. PubMed ID: 20980593
[TBL] [Abstract][Full Text] [Related]
33. Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease.
Sun KH; Lee HG; Smith MA; Shah K
Mol Biol Cell; 2009 Nov; 20(21):4611-9. PubMed ID: 19776350
[TBL] [Abstract][Full Text] [Related]
34. S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration.
Nakamura T; Cieplak P; Cho DH; Godzik A; Lipton SA
Mitochondrion; 2010 Aug; 10(5):573-8. PubMed ID: 20447471
[TBL] [Abstract][Full Text] [Related]
35. Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology.
Sheng Y; Zhang L; Su SC; Tsai LH; Julius Zhu J
Cereb Cortex; 2016 Jul; 26(7):2937-51. PubMed ID: 26088971
[TBL] [Abstract][Full Text] [Related]
36. Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer's Disease Pathogenesis.
Nikhil K; Viccaro K; Shah K
Mol Neurobiol; 2019 Feb; 56(2):1366-1390. PubMed ID: 29948941
[TBL] [Abstract][Full Text] [Related]
37. Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease.
Sun KH; de Pablo Y; Vincent F; Johnson EO; Chavers AK; Shah K
Mol Biol Cell; 2008 Jul; 19(7):3052-69. PubMed ID: 18480410
[TBL] [Abstract][Full Text] [Related]
38. Peroxiredoxin 5 Decreases Beta-Amyloid-Mediated Cyclin-Dependent Kinase 5 Activation Through Regulation of Ca
Park J; Kim B; Chae U; Lee DG; Kam MK; Lee SR; Lee S; Lee HS; Park JW; Lee DS
Antioxid Redox Signal; 2017 Oct; 27(11):715-726. PubMed ID: 28358580
[TBL] [Abstract][Full Text] [Related]
39. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
Nakamura T; Lipton SA
Apoptosis; 2010 Nov; 15(11):1354-63. PubMed ID: 20177970
[TBL] [Abstract][Full Text] [Related]
40. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
Maccioni RB; Otth C; Concha II; Muñoz JP
Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
